BAY 81‐8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

BAY 81‐8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial

Authors:	R. Ljung G. Kenet M. E. Mancuso V. Kaleva L. Rusen D. Tseneklidou‐Stoeter L. A. Michaels A. Shah M. Maas Enriquez the investigators of the LEOPOLD Kids Trial

Affiliation:	1. Department of Clinical Sciences Lund‐Pediatrics, Malm? Centre for Thrombosis and Haemostasis, Sk?ne University Hospital, Lund University, Malm?, Sweden;2. Chaim Sheba Medical Center, The Israeli National Hemophilia Center, The Sackler Medical School, Tel Aviv University, Tel‐Hashomer, Israel;3. Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy;4. MHAT Sveta Marina, Clinic of Pediatric Hematology and Oncology, Varna, Bulgaria;5. SC Sanador SRL, Bucharest, Romania;6. Bayer Pharma AG, Berlin, Germany;7. Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA;8. Bayer Pharma AG, Wuppertal, Germany

Abstract:

Keywords:	children clinical trial factor VIII haemophilia A prophylaxis